One increasingly documented tendency of COVID-19 patients is to exhibit neuropsychiatric
and neurological symptoms. Here we found that anxiety and cognitive impairment are …

Background Fatigue and cognitive complaints are the most frequent persistent symptoms in
patients after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This …

Importance Published data about the impact of poststroke seizures (PSSs) on the outcomes
of patients with stroke are inconsistent and have not been systematically evaluated, to the …

Background and purpose The aim of this study was to assess the neurological complications
of SARS‐CoV‐2 infection and compare phenotypes and outcomes in infected patients with …

Although post-acute cognitive dysfunction and neuroimaging abnormalities have been
reported after hospital discharge in patients recovered from COVID-19, little is known about …

Although some studies have shown neuroimaging and neuropsychological alterations in
post-COVID-19 patients, fewer combined neuroimaging and neuropsychology evaluations of …

Background The expression of serine protease granzyme-B (GzmB) by circulating CD8 + T
lymphocytes has been recently suggested as a biomarker for poor immunotherapy response …

Background: Neuropsychiatric disorders are a significant cause of death and disability
worldwide. The mechanisms underlying these disorders include a constellation of structural, …

The treatment of epilepsy has advanced over the past 30 years through the development of
new antiseizure medications (ASMs). Unfortunately, not all of them have been approved yet …

Few resting-state functional magnetic resonance imaging (RS-fMRI) studies evaluated the
impact of acute ischemic changes on cerebral functional connectivity (FC) and its relationship …